Sangamo Therapeutics
SGMO
#8849
Rank
C$0.20 B
Marketcap
C$0.62
Share price
-1.98%
Change (1 day)
-83.57%
Change (1 year)

Earnings for Sangamo Therapeutics (SGMO)

Earnings in 2025 (TTM): -C$0.16 Billion

According to Sangamo Therapeutics 's latest financial reports the company's current earnings are C$32.87 Million. In 2024 the company made an earning of -C$0.14 Billion, an increase over its 2023 earnings that were of -C$0.17 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Sangamo Therapeutics from 2000 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -C$0.16 Billion13.45%
2024 -C$0.14 Billion-17.27%
2023 -C$0.17 Billion-40.88%
2022 -C$0.28 Billion9.79%
2021 -C$0.26 Billion41.52%
2020 -C$0.18 Billion23.17%
2019 -C$0.15 Billion36.33%
2018 -C$0.11 Billion36.89%
2017 -C$77.58 Million-22.32%
2016 -C$99.87 Million54.86%
2015 -C$64.49 Million75.62%
2014 -C$36.73 Million0.13%
2013 -C$36.68 Million
2011 -C$49.31 Million43.66%
2010 -C$34.32 Million28.52%
2009 -C$26.71 Million-23.55%
2008 -C$34.93 Million2.45%
2007 -C$34.1 Million19.5%
2006 -C$28.54 Million50.78%
2005 -C$18.93 Million75%
2004 -C$10.82 Million-33.25%
2003 -C$16.2 Million-62.27%
2002 -C$42.94 Million102.82%
2001 -C$21.17 Million23.21%
2000 -C$17.19 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Gilead Sciences
GILD
C$13.60 B-9,167.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
C$0.17 B-219.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
C$11.34 B-7,661.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
C$2.62 B-1,846.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Dow
DOW
-C$1.03 Billion 582.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
C$44.58 B-29,814.01%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
C$0.93 B-723.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
C$31.77 B-21,278.43%๐Ÿ‡บ๐Ÿ‡ธ USA